FDA Still Under Gun On Antibiotics, Despite Hopeful Signs
Antibiotic development is showing signs of life after years of hibernation, with multiple drugs becoming eligible for quicker approval and extra exclusivity in the year since Congress created those key incentives,...To view the full article, register now.
Already a subscriber? Click here to view full article